M6K-26639-70333
4 vaccinations
6 coded responses
41 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 294 / SC
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-06
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-01-11
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-13
- 2021-01-14
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-17
- 2021-01-18
- 2021-01-25
-
2021-02-01
Survey response — day 21, dose 2MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Rash on legsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-08
- 2021-02-12
- 2021-02-15
- 2021-02-22
-
2021-04-14
Survey response — 3 months, dose 2MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Significant Rash. Total body.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-15
-
2021-07-12
Survey response — 6 months, dose 2MedDRA: Fatigue, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea, Upper respiratory tract infection — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Upper respiratory infection (congestion, runny nose, fatigue, sore throat)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-03
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Survey response — day 21, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Lymphadenopathy after 3rd injection. Self resolved.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-08
- 2021-10-15
- 2021-12-03
- 2022-03-06
- 2022-09-03
-
2022-10-07
Dose 4 — Pfizer-BioNTech
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-13
- 2022-10-14
-
2022-10-21
Survey response — day 14, dose 4MedDRA: Diarrhoea — Feeling: GoodFree text: DiarrheaMedDRA releases: 2024-11 · check-in free text available
- 2022-10-30
-
2022-11-06
Survey response — day 28, dose 4MedDRA: Nausea — Feeling: Good · Be unable to do your normal daily activitiesFree text: NauseaMedDRA releases: 2024-11 · check-in free text available
- 2022-11-18
- 2023-01-08
- 2023-04-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-09-03 | Pfizer-BioNTech | No |
| 4 | 2022-10-07 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 unsuccessful
Free text
Release 3 — day 21, dose 2
Symptoms: Rash on legs
Release 7 — 3 months, dose 2
Symptoms: Significant Rash. Total body.
Release 9 — 6 months, dose 2
Symptoms: Upper respiratory infection (congestion, runny nose, fatigue, sore throat)
Release 9 — day 21, dose 3
Symptoms: Lymphadenopathy after 3rd injection. Self resolved.
Release 12 — day 14, dose 4
Symptoms: Diarrhea
Release 12 — day 28, dose 4
Symptoms: Nausea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release